Search Result "phase 3 clinicaltrials"


Review Article

Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure

Journal: Current Drug Targets
Volume: 22 Issue: 13 Year: 2021 Page: 1568-1576
Author(s): Ubaid Tariq,Shravan K. Uppulapu,Sanjay K. Banerjee

Clinical Trial open access plus

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL

Journal: Current Cancer Drug Targets
Volume: 20 Issue: 10 Year: 2020 Page: 811-817
Author(s): Sven Nilsson,Alexander Stein,Christian Rolfo,Anne L. Kranich,Julia Mann,Konstantinos Papadimitriou,Susann Theile,Stefanie Amberg,Carsten Bokemeyer

Review Article

An Outline of Contributing Vaccine Technologies for SARS CoV2Advancing in Clinical and Preclinical Phase-Trials

Journal: Recent Patents on Biotechnology
Volume: 16 Issue: 2 Year: 2022 Page: 122-143
Author(s): Sheikh Saba Naz

Review Article

An Updated Review For Hyperuricemia and Gout Management;Special Focus on the Available Drug Delivery Systems and ClinicalTrials

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 36 Year: 2024 Page: 5856-5883
Author(s): Ioannis D. Karantas,Androulla N. Miliotou,Panoraia I. Siafaka

Translational Gap in Glioma Research

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 8 Year: 2014 Page: 1110-1120
Author(s): Chi Ma,Gang Zhao,Mabel Hilda Cruz,Ake Siden,Juan Sebastian Yakisich

Perspective

Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast GrowthFactor Receptors for Treatment of the Bile Duct Cancer

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 6 Year: 2024 Page: 666-670
Author(s): Surya K. De

Recent Advances of Diaryl Ether Family as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2829-2838
Author(s): Xuwang Chen, Shufang Ding, Peng Zhan, Xinyong Liu

Review Article

Developments of Fms-like Tyrosine Kinase 3 Inhibitors as AnticancerAgents for AML Treatment

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4657-4686
Author(s):

Review Article

NLS-3 (Levophacetoperane or (R,R) Phacetoperane): A Reverse Esterof Methylphenidate: A Literature Review

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 9 Year: 2024 Page: 1069-1081
Author(s):

Utilizing Blockchain Technology to Improve Clinical Trials

Ebook: Blockchain Technology in Healthcare - Concepts, Methodologies, and Applications
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815165197123010004

Previous   Next

Go To   Results 1 - 1 of 857

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy